Abstract
Hyperprolactinemia is a common side effect of antipsychotic treatments. Existing alternatives to resolve this problem include decreasing the antipsychotic dose or switching to a different antipsychotic agent. Nevertheless, said modifications can sometimes lead to decompensation of the patient. We report a clinical case of a female patient in whom the combined treatment of 5 mg/day of aripiprazole (5 mg/day) reversed paliperidoneinduced hyperprolactinemia within four weeks.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Antipsychotic Agents / adverse effects
-
Antipsychotic Agents / therapeutic use*
-
Aripiprazole
-
Female
-
Humans
-
Hyperprolactinemia / chemically induced*
-
Hyperprolactinemia / drug therapy*
-
Isoxazoles / adverse effects*
-
Paliperidone Palmitate
-
Piperazines / therapeutic use*
-
Pyrimidines / adverse effects*
-
Quinolones / therapeutic use*
Substances
-
Antipsychotic Agents
-
Isoxazoles
-
Piperazines
-
Pyrimidines
-
Quinolones
-
Aripiprazole
-
Paliperidone Palmitate